A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
Recruiting · NCT07500506 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine | Bacterial Infections and Mycoses, Borrelia infectious disease, Infections, Lyme disease, bacterial infectious disease, gram-negative bacterial infections, spirochaetales infections, tick-borne infectious disease, vector-borne disease | Recruiting | Phase 3 | 2026-05-06 | NCT07500506 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pfizer | 431 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.